Article: Hoffman-La Roche offers to acquire Sterling Drug Inc. for $72 per share.

HOFFMAN-LA ROCHE OFFERS TO ACQUIRE STERLING DRUG INC.

FOR $72 PER SHARE

NEW YORK, Jan. 4 /PRNewswire/ -- Fritz Gerber, chairman and chief executive officer of Hoffmann-La Roche announced today that the following letter had been sent to John M. Pietruski, chairman and chief executive officer of Sterling Drug Inc.

F. Hoffmann-La Roche and Company is a leading worldwide pharmaceutical company whose primary focus is prescription medicines, with emphasis on anti-infectives, dermatologicals, cardiovasculars, anti-inflammatories and biotechnologically derived products and products for the treatment of the central nervous system. ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!